SYK - חוב לטווח ארוך Stryker Inc

Stryker Corporation maintains its premium status in the medtech sector due to physicians' trust in the quality of its implants. Changes in the company's long-term debt clearly illustrate the financial dynamics, where 15.23 becomes the new value of the indicator. However, geopolitical tensions and chip shortages are slowing production. Strict FDA regulations and the high costs for clinics to switch suppliers cement the leadership of SYK.

This indicator measures the total volume of liabilities with a maturity exceeding one year, defining the long-term capital structure. This metric reflects the company's ability to secure stable financing for business scaling without operational risks. Stryker Corporation (SYK) utilizes borrowed funds to develop robotics and 3D printing in partnership with clinics. Analyzing the history of the corporation's long-term loans and borrowings allows for an assessment of the investment program's sustainability.